Printer Friendly

Rosetta Genomics Ltd to take part at the upcoming American Society of Human Genetics Annual Meeting 2013 in Boston.

M2 EQUITYBITES-October 18, 2013-Rosetta Genomics Ltd to take part at the upcoming American Society of Human Genetics Annual Meeting 2013 in Boston(C)2013 M2 COMMUNICATIONS http://www.m2.com

Molecular diagnostics company Rosetta Genomics Ltd (NASDAQ:ROSG) said on Thursday that it will present its Cancer Origin Test at the upcoming American Society of Human Genetics Annual Meeting 2013 (ASHG 2013) at the Boston Convention and Exhibition Center.

The company added that the poster presentation has been scheduled between 22-26 October 2013 in Boston.

In addition, the company stated the posters will be available for viewing beginning 23 October at 10:30 until 25 October at 14:00.

According to the company, its Cancer Origin Test 'Value of microRNA-based molecular profiling in Cancer of Unknown Primary (CUP) cases for familial cancer risk assessment and genetic counseling', will be presented by study author and medical geneticist, E. Robert Wassman, MD, FAAP, FACMG, and its chief medical officer.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:1U1MA
Date:Oct 18, 2013
Words:168
Previous Article:MiMedx Group Inc's meeting with the FDA rescheduled to 28 October 2013.
Next Article:Iron Mountain pays USD191m for purchase of sector firm.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |